Nicholas McGrane, Chief Financial Officer at Evolent Health, Inc. (EVH), sold 1,667 shares at $25.40 ($41K) on 2017-06-12, disclosed to the SEC on 2017-06-14.
Scheduled sale ($41k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.53 | 1,567 | $38K | 93.8% |
| 2 | $25.40 | 100 | $3K | 6.2% |
| Total | $24.58 avg | 1,667 | $41K | 100% |
| Filing → |
| EVH | SELL | 2017-05-23 | $2.3M | — | Filing → |
| EVH | SELL | 2017-05-12 | $40K | — | Filing → |
| EVH | SELL | 2017-04-21 | $38K | — | Filing → |